REQUEST A DEMO
Total
USD $0.00
Search more companies

Kedrion Betaphar Biyofarmasotik Ilac A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Kedrion Betaphar Biyofarmasotik Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2019 Available in: English Download a sample report

Kedrion Biopharma TR is a biopharmaceutical company that specializes in developing, producing, and distributing plasma-based therapeutic products for severe diseases, immune system disabilities, and coagulation disorders. Kedrion Biopharma offers a wide range of therapies for rare and uncomfortable illnesses and disorders, with a claimed strong presence in Turkey. The company aims to provide closer service to patients and expand its product portfolio. Kedrion Biopharma is a player in the plasma-based and rare diseases market and has recently joined forces with Bio Products Laboratory to strengthen its role as a reputable partner in the medical and scientific environments and agencies.

Headquarters
No:18-1 Cankaya Mahallesi Cemal Nadir Sokak Cankaya
Ankara; Central Anatolia; Postal Code: 06690

Contact Details: Purchase the Kedrion Betaphar Biyofarmasotik Ilac A.S. report to view the information.

Website: http://www.kedrion.com.tr

Basic Information
Total Employees:
Purchase the Kedrion Betaphar Biyofarmasotik Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Kedrion Betaphar Biyofarmasotik Ilac A.S. report to view the information.
Incorporation Date:
November 29, 2012
Key Executives
Purchase this report to view the information.
Chairman
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
No results were found for this company.

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?